(KNTK) Kinetik Holdings - Overview
Stock: Gathering, Processing, Pipeline, NGL, Condensate
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.91% |
| Yield on Cost 5y | 16.61% |
| Yield CAGR 5y | -15.08% |
| Payout Consistency | 95.8% |
| Payout Ratio | 5.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.9% |
| Relative Tail Risk | 1.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.91 |
| Alpha | -46.75 |
| Character TTM | |
|---|---|
| Beta | 1.098 |
| Beta Downside | 1.748 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.98% |
| CAGR/Max DD | 0.42 |
Description: KNTK Kinetik Holdings January 13, 2026
Kinetik Holdings Inc. (NYSE: KNTK) is a midstream operator focused on the Texas Delaware Basin, delivering gathering, compression, processing, stabilization, treatment, storage, and pipeline transportation services to natural-gas, NGL, and crude-oil producers. The business is organized into two segments-Midstream Logistics and Pipeline Transportation-and also provides water-gathering and disposal solutions, while generating ancillary revenue from sales of condensates, natural-gas residue, and NGLs. Founded in 2017 and headquartered in Midland, Texas, KNTK trades under the Oil & Gas Storage & Transportation sub-industry.
Key operational metrics (as of the latest 2023 filing) include approximately 1.1 billion cubic feet per day (Bcf/d) of gas processing capacity and roughly 150,000 barrels per day (bpd) of water-disposal capability, supporting the rapid output growth in the Permian Basin. Adjusted EBITDA for 2023 was about $84 million, reflecting a utilization rate near 85 % for its core assets. The company’s cash-flow sensitivity is closely tied to regional natural-gas price spreads and the ongoing capital-intensity of water-management in a basin that is experiencing a 10-12 % annual increase in hydrocarbon production.
For a deeper quantitative view, you might explore KNTK’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 66.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -4.20 > 1.0 |
| NWC/Revenue: -10.77% < 20% (prev -7.80%; Δ -2.97% < -1%) |
| CFO/TA 0.10 > 3% & CFO 697.1m > Net Income 66.6m |
| Net Debt (4.13b) to EBITDA (495.7m): 8.33 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.1m) vs 12m ago 6.09% < -2% |
| Gross Margin: 30.76% > 18% (prev 0.38%; Δ 3038 % > 0.5%) |
| Asset Turnover: 24.99% > 50% (prev 21.08%; Δ 3.91% > 0%) |
| Interest Coverage Ratio: 0.99 > 6 (EBITDA TTM 495.7m / Interest Expense TTM 223.0m) |
Altman Z'' -1.32
| A: -0.03 (Total Current Assets 315.1m - Total Current Liabilities 504.3m) / Total Assets 7.20b |
| B: -0.28 (Retained Earnings -2.00b / Total Assets 7.20b) |
| C: 0.03 (EBIT TTM 219.7m / Avg Total Assets 7.03b) |
| D: -0.44 (Book Value of Equity -2.00b / Total Liabilities 4.58b) |
| Altman-Z'' Score: -1.32 = CCC |
Beneish M -3.41
| DSRI: 0.30 (Receivables 77.4m/215.6m, Revenue 1.76b/1.45b) |
| GMI: 1.24 (GM 30.76% / 38.08%) |
| AQI: 0.86 (AQ_t 0.42 / AQ_t-1 0.48) |
| SGI: 1.21 (Revenue 1.76b / 1.45b) |
| TATA: -0.09 (NI 66.6m - CFO 697.1m) / TA 7.20b) |
| Beneish M-Score: -3.41 (Cap -4..+1) = AA |
What is the price of KNTK shares?
Over the past week, the price has changed by +0.32%, over one month by +12.02%, over three months by +9.35% and over the past year by -33.05%.
Is KNTK a buy, sell or hold?
- StrongBuy: 3
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KNTK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.5 | 11.6% |
| Analysts Target Price | 45.5 | 11.6% |
| ValueRay Target Price | 47.3 | 15.8% |
KNTK Fundamental Data Overview February 03, 2026
P/E Forward = 19.0114
P/S = 1.5232
P/B = 1.3294
P/EG = 8.6228
Revenue TTM = 1.76b USD
EBIT TTM = 219.7m USD
EBITDA TTM = 495.7m USD
Long Term Debt = 3.96b USD (from longTermDebt, last quarter)
Short Term Debt = 178.6m USD (from shortLongTermDebt, last quarter)
Debt = 3.53b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 4.13b USD (from netDebt column, last quarter)
Enterprise Value = 6.15b USD (2.62b + Debt 3.53b - CCE 7.74m)
Interest Coverage Ratio = 0.99 (Ebit TTM 219.7m / Interest Expense TTM 223.0m)
EV/FCF = 38.51x (Enterprise Value 6.15b / FCF TTM 159.6m)
FCF Yield = 2.60% (FCF TTM 159.6m / Enterprise Value 6.15b)
FCF Margin = 9.08% (FCF TTM 159.6m / Revenue TTM 1.76b)
Net Margin = 3.79% (Net Income TTM 66.6m / Revenue TTM 1.76b)
Gross Margin = 30.76% ((Revenue TTM 1.76b - Cost of Revenue TTM 1.22b) / Revenue TTM)
Gross Margin QoQ = 28.70% (prev 34.08%)
Tobins Q-Ratio = 0.85 (Enterprise Value 6.15b / Total Assets 7.20b)
Interest Expense / Debt = 1.69% (Interest Expense 59.8m / Debt 3.53b)
Taxrate = 6.66% (1.11m / 16.7m)
NOPAT = 205.1m (EBIT 219.7m * (1 - 6.66%))
Current Ratio = 0.62 (Total Current Assets 315.1m / Total Current Liabilities 504.3m)
Debt / Equity = -1.99 (negative equity) (Debt 3.53b / totalStockholderEquity, last quarter -1.78b)
Debt / EBITDA = 8.33 (Net Debt 4.13b / EBITDA 495.7m)
Debt / FCF = 25.86 (Net Debt 4.13b / FCF TTM 159.6m)
Total Stockholder Equity = -2.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.95% (Net Income 66.6m / Total Assets 7.20b)
RoE = -2.93% (negative equity) (Net Income TTM 66.6m / Total Stockholder Equity -2.27b)
RoCE = 13.02% (EBIT 219.7m / Capital Employed (Equity -2.27b + L.T.Debt 3.96b))
RoIC = 12.79% (NOPAT 205.1m / Invested Capital 1.60b)
WACC = 5.15% (E(2.62b)/V(6.15b) * Re(9.96%) + D(3.53b)/V(6.15b) * Rd(1.69%) * (1-Tc(0.07)))
Discount Rate = 9.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.11%
[DCF Debug] Terminal Value 86.43% ; FCFF base≈271.8m ; Y1≈274.3m ; Y5≈295.9m
Fair Price DCF = 73.24 (EV 8.82b - Net Debt 4.13b = Equity 4.69b / Shares 64.0m; r=5.90% [WACC]; 5y FCF grow 0.54% → 2.90% )
EPS Correlation: -19.12 | EPS CAGR: -41.08% | SUE: -0.65 | # QB: 0
Revenue Correlation: 91.11 | Revenue CAGR: 22.11% | SUE: 1.12 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.27 | Chg30d=-0.070 | Revisions Net=-2 | Analysts=2
EPS next Year (2026-12-31): EPS=1.62 | Chg30d=-0.276 | Revisions Net=+0 | Growth EPS=-7.3% | Growth Revenue=+10.7%